Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Indianapolis, Indiana 46202


Purpose:

This 8-week, prospective open-label study will investigate the effectiveness and tolerability of paliperidone ER in adolescents and young adults with autism. Hypothesis:Paliperidone Er will be well tolerated and efficacious for reducing aggression, self-injury, and irritability in adolescents and young adults.


Criteria:

Inclusion Criteria: - Males and females between ages of 12 and 21 years - Tanner Sage III or IV (post-pubertal) - Diagnostic and Statistical Manual Fourth Edition Text-Revised (DSM-IV-TR) diagnosis of autism - Outpatient - Ability to swallow pills - Antipsychotic medication-free for at least 2 weeks - Score of 4 or more on the Clinical Global Impressions Severity Scale - Score of 18 or higher on the Aberrant Behavior Checklist Irritability Scale - Mental age of 18 months or greater based on testing - Subjects must be in good physical health Exclusion Criteria: - Asperger's Disorder, Pervasive Developmental Disorder Not Otherwise Specified (PDD NOS), Rett's Disorder, childhood disintegrative disorder, schizophrenia, bipolar disorder, Fragile X Syndrome, Tuberous Sclerosis - A significant medical condition - An active seizure disorder - Females who are pregnant - Evidence of a prior adequate trial of paliperidone ER - History of neuroleptic malignant syndrome - Hypersensitivity to paliperidone ER


NCT ID:

NCT00549562


Primary Contact:

Principal Investigator
Kimberly A Stigler, MD
Indiana Univerity School of Medicine


Backup Contact:

N/A


Location Contact:

Indianapolis, Indiana 46202
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 21, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.